Marvel Biosciences Announces Private Placement for up to $2.5 Million

Calgary, Alberta--(Newsfile Corp. - January 7, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) ("Marvel" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement of common shares of ‎the Company (each a "Common Share") at a price of $0.15 per Common Share for gross ‎proceeds of a minimum of $1,935,000 and up to a maximum of $2,500,000 (the "Offering").‎It is anticipated that the net proceeds from the Offering will be used to pay a deposit for phase ...